Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
about
Sodium-Glucose linked transporter 2 (SGLT2) inhibitors--fighting diabetes from a new perspective.Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus: A meta-analysis.Tofogliflozin: the road goes ever on.
P2860
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@en
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@nl
type
label
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@en
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@nl
prefLabel
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@en
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@nl
P2860
P1476
Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
@en
P2093
Kerry McIntyre
Sheila A Doggrell
P2860
P304
P356
10.1517/14656566.2014.868885
P407
P577
2013-12-31T00:00:00Z